The store will not work correctly when cookies are disabled.
4-(1-methyl-5-nitro-2-oxoindolin-3-ylideneamino)benzenesulfonamide
ID: ALA3785289
PubChem CID: 127031289
Max Phase: Preclinical
Molecular Formula: C15H12N4O5S
Molecular Weight: 360.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN1C(=O)/C(=N\c2ccc(S(N)(=O)=O)cc2)c2cc([N+](=O)[O-])ccc21
Standard InChI: InChI=1S/C15H12N4O5S/c1-18-13-7-4-10(19(21)22)8-12(13)14(15(18)20)17-9-2-5-11(6-3-9)25(16,23)24/h2-8H,1H3,(H2,16,23,24)/b17-14-
Standard InChI Key: YUTOWHVJOWFFPO-VKAVYKQESA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
8.4333 4.9910 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0567 3.8517 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.8554 2.9561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7889 0.0269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1200 4.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5886 4.6654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5873 3.5462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1174 2.1217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6488 1.8163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2317 4.0953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 1.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6251 2.6919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6549 0.8867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
11 13 2 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 2 1 0
2 21 1 0
22 23 2 0
22 24 1 0
4 22 1 0
10 25 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.35 | Molecular Weight (Monoisotopic): 360.0528 | AlogP: 1.34 | #Rotatable Bonds: 3 |
Polar Surface Area: 135.97 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.15 | CX Basic pKa: ┄ | CX LogP: 1.52 | CX LogD: 1.52 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.65 | Np Likeness Score: -1.68 |
References
1. Akdemir A, Güzel-Akdemir Ö, Karalı N, Supuran CT.. (2016) Isatin analogs as novel inhibitors of Candida spp. β-carbonic anhydrase enzymes., 24 (8): [PMID:26951893] [10.1016/j.bmc.2016.02.036] |